Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

729 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia.
Remberger M, Mattsson J, Hausenberger D, Schaffer M, Svahn BM, Ringdén O. Remberger M, et al. Among authors: mattsson j. Eur J Haematol. 2008 May;80(5):419-28. doi: 10.1111/j.1600-0609.2008.01047.x. Epub 2008 Feb 13. Eur J Haematol. 2008. PMID: 18284619
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
Ringdén O, Remberger M, Dahllöf G, Garming-Legert K, Karlsson H, Svenberg P, Uhlin M, Uzunel M, Mattsson J. Ringdén O, et al. Among authors: mattsson j. Eur J Haematol. 2011 Dec;87(6):503-9. doi: 10.1111/j.1600-0609.2011.01685.x. Epub 2011 Oct 2. Eur J Haematol. 2011. PMID: 22974354 Clinical Trial.
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.
Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH. Shapiro RM, et al. Among authors: mattsson j. Biol Blood Marrow Transplant. 2019 Sep;25(9):1761-1769. doi: 10.1016/j.bbmt.2019.05.029. Epub 2019 Jun 4. Biol Blood Marrow Transplant. 2019. PMID: 31170520 Free article. Clinical Trial.
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.
Salas MQ, Prem S, Atenafu EG, Law AD, Lam W, Al-Shaibani Z, Loach D, Kim DDH, Michelis FV, Lipton JH, Kumar R, Mattsson J, Viswabandya A. Salas MQ, et al. Among authors: mattsson j. Eur J Haematol. 2019 Nov;103(5):510-518. doi: 10.1111/ejh.13321. Epub 2019 Sep 9. Eur J Haematol. 2019. PMID: 31449699 Clinical Trial.
729 results